Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation

European Radiology

Volumn 22, Issue 11, 2012, Pages 2319-2327

  Somoye, Gbolahan ^a   Harry, Vanessa ^b   Semple, Scott ^c   Plataniotis, George ^d   Scott, Neil ^e   Gilbert, Fiona J ^f   Parkin, David ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d MUSGROVE PARK HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apparent diffusion coefficient; Cervical cancer; Chemo radiotherapy; Diffusion weighted magnetic resonance imaging (DWI); Survival

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER SURVIVOR; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84870366650     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2496-0     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, GLOBOCAN (2008) Cancer incidence and mortality worldwide: IARC CancerBase no. 10. International Agency for Research on Cancer, Lyon. Available via http://www.globocan.iarc.fr. Accessed 11 Jan 2011
2. Cancer Research UK (2010) Cervical cancer: survival statistics. Available via http://info.cancerresearchuk.org/cancerstats. Accessed 5 Nov 2010
3. Green JA, Kirwan JM, Tierney JF et al (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and metaanalysis. Lancet 358: 781-786
4. Balleyguier C, Sala E, Da Cunha T et al (2011) Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol 21: 1102-1110
5. Lee DW, Kim YT, Kim JH et al (2010) Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy. J Gynecol Oncol 1: 18-23
6. Amano M, Kato T, Amano Y, Kumazaki T (1998) Using MR imaging to predict and evaluate the response of invasive cervical carcinoma to systemic chemotherapy. AJR Am J Roentgenol 171: 1335-1339
7. Padhani AR, Liu G, Kohl DM et al (2009) Diffusion weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11: 102-125
8. Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188: 1622-1635
9. Harry VN, Semple SI, Gilbert FJ, Parkin DE (2008) Diffusionweighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111: 213-220
10. Theilmann RJ, Borders R, Trouard TP et al (2004) Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 6: 831-837
11. Liapi E, Geschwind JF, Vossen JA et al (2008) Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. AJR Am J Roentgenol 190: 67-73
12. Vossen JA, Kamel IR, Buijs M et al (2008) Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr 32: 347-352
13. Lee KC, Moffat BA, Schott AF et al (2007) Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 13: 443-450
14. Galbán CJ, Mukherji SK, Chenevert TL et al (2009) A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2: 184-190
15. Pickles MD, Gibbs P, Lowry M, Turnbull LW (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24: 843-847
16. Kim SH, Lee JM, Hong SH et al (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumour response to neoadjuvant chemo and radiation therapy. Radiology 253: 116-125
17. Bodurka-Bevers D, Morris M, Eifel PJ et al (2000) Post therapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol 78: 187-193
18. Hong JH, Tsai CS, Lai CH et al (2004) Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 60: 249-257
19. Chen J, Zhang Y, Liang B, Yang Z (2010) The utility of diffusionweighted MR imaging in cervical cancer. Eur J Radiol 74: 101-106
20. McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA (2008) Diffusion-weighted MRI in cervical cancer. Eur Radiol 18: 1058-1064
21. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O (2005) Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15: 71-78
22. Zhao M, Pipe JG, Bonnett J, Evelhoch JL (1996) Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73: 61-64
23. Lemaire L, Howe FA, Rodrigues LM, Griffiths JR (1999) Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo. MAGMA 8: 20-26
24. Vandecaveye V, Dirix P, De Keyzer F et al (2010) Predictive value of diffusion-weighted magnetic resonance during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 20: 1703-1714
25. DeVries A, Kremser C, Hein P et al (2003) Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 56: 958-965
26. Lee KC, Bradley DA, Hussain M et al (2007) A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 9: 1003-1011
27. Mardor Y, Roth Y, Ochershvilli A et al (2004) Pretreatment prediction of brain tumors response to radiation therapy using high bvalue diffusion-weighted MRI. Neoplasia 6: 136-142
28. Koh DM, Scurr E, Collins D et al (2007) Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 188: 1001-1008
29. Byun WM, Shin SO, Chang Y, Lee SJ, Finsterbusch J, Frahm J (2002) Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy. AJNR Am J Neuroradiol 23: 906-912
30. Moffat BA, Chenevert TL, Lawrence TS et al (2005) Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 102: 5524-5529
31. Park SH, Moon WK, Cho N et al (2010) Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 257: 56-63
32. Sun YS, Zhang XP, Tang L et al (2010) Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 254: 170-178
33. Hamstra DA, Galbán CJ, Meyer CR et al (2008) Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol 26: 3387-3394
34. Hamstra DA, Chenevert TL, Moffat BA et al (2005) Evaluation of the functional diffusion map as an early biomarker of time-toprogression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 102: 16759-16764
35. Barajas RF Jr, Rubenstein JL, Chang JS, Hwang J, Cha S (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 31: 60-66
36. Yokoyama Y, Takano T, Nakahara K et al (2008) A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study. Oncol Rep 19: 1551-1556
37. Niibe Y, Tsunoda S, Jobo T et al (2008) Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501) initial analysis. Eur J Gynaecol Oncol 29: 222-224
38. Franckena M, Lutgens LC, Koper PC (2009) Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients. Int J Radiat Oncol Biol Phys 73: 242-250
39. Plataniotis G, Dale RG (2009) Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results. Int J Radiat Oncol Biol Phys 73: 1538-1544
40. Scottish Intercollegiate Guidelines Network (2008) 99 Management of cervical cancer. A national clinical guideline. NHS Quality Improvement Scotland. Available via http://www.sign.ac.uk. Accessed 24 Mar 2011